title: Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
abstract: The neurotransmitter serotonin (5-HT) possesses several receptors and their subtypes, some of which are polymorphic, such as the 5-HT(2C) receptor. The latter has been implicated in the control of neuroendocrine function, and has been discussed in the pathophysiology and pharmacotherapy of psychiatric disorders such as obsessive-compulsive disorder, panic disorder and bipolar affective disorder. To investigate whether the 5-HT(2C) receptor polymorphism contributes to the variation of neuroendocrinological responses elicited by activation of the hypothalamic-pituitary axis, we performed an m-chlorophenylpiperazine (m-CPP) challenge and monitored m-CPP and ACTH, cortisol and prolactin plasma levels in 16 healthy male volunteers carrying the common 5-HT(2C)-cys-23 receptor gene and 16 healthy male volunteers carrying the less frequent 5-HT(2C)-ser-23 receptor gene. The 5-HT(2C) polymorphism contributed little to the variation of the scores regarding hormonal responses of ACTH, cortisol and prolactin to the m-CPP challenge. The group carrying the rare 5-HT(2C)-ser-23 receptor gene showed a faster and stronger but not statistically significant ACTH response to the challenge. However, it is noteworthy that there is a 'medium' effect size of the ACTH response according to the conventions of Cohen, and thus comparable to other studies. Both groups show similar major scores in the Temperament and Character Inventory (TCI).
authors.affiliation: University of Bonn, Department of Psychiatry, Germany. k.u.kuehn@uni-bonn.de
authors.forename: K-U
authors.initials: KU
authors.lastname: Kühn
authors.forename: B B
authors.initials: BB
authors.lastname: Quednow
authors.forename: M
authors.initials: M
authors.lastname: Bagli
authors.forename: K
authors.initials: K
authors.lastname: Meyer
authors.forename: A
authors.initials: A
authors.lastname: Feuchtl
authors.forename: J
authors.initials: J
authors.lastname: Westheide
authors.forename: C
authors.initials: C
authors.lastname: Frahnert
authors.forename: W
authors.initials: W
authors.lastname: Maier
authors.forename: M L
authors.initials: ML
authors.lastname: Rao
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000483:Alleles; D000704:Analysis of Variance; D019540:Area Under Curve; D003545:Cysteine / Q000235:genetics; D005838:Genotype; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism; D008297:Male; D009490:Neurosecretory Systems / Q000187:drug effects* / Q000502:physiology; D010879:Piperazines / Q000097:blood / Q000494:pharmacology*; D011110:Polymorphism, Genetic; D011388:Prolactin / Q000097:blood; D044405:Receptor, Serotonin, 5-HT2C; D011985:Receptors, Serotonin / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D012694:Serine / Q000235:genetics; D017366:Serotonin Receptor Agonists / Q000097:blood / Q000494:pharmacology*
chemical_list: D010879:Piperazines; D044405:Receptor, Serotonin, 5-HT2C; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D012694:Serine; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D003545:Cysteine; C015068:1-(3-chlorophenyl)piperazine; D006854:Hydrocortisone